pISSN 2234-3806eISSN 2234-3814
Table. 1.
Clinical characteristics of 34 patients with Bacteroides fragilis infection
| Characteristic | Value |
|---|---|
| Age, yrs | 65.5±18.7 |
| Female sex | 13 (32.5) |
| Underlying comorbidities | |
| Diabetes mellitus | 9 (26.5) |
| Non-metastatic cancer | 8 (23.5) |
| Chronic liver disease | 6 (17.6) |
| Chronic renal disease | 5 (14.7) |
| Metastatic solid tumor | 4 (11.8) |
| Dementia | 3 (8.8) |
| Cerebrovascular accident | 2 (5.9) |
| Chronic pulmonary disease | 2 (5.9) |
| Myocardial infarction | 2 (5.9) |
| Congestive heart failure | 2 (5.9) |
| Peripheral vascular disease | 1 (2.9) |
| Hemiplegia | 1 (2.9) |
| Other medical conditions | |
| Chemotherapeutic agents | 1 (2.9) |
| Immunosuppressants | 3 (8.8) |
| Bedridden status | 5 (14.7) |
| History of admission within the past 3 months | 12 (35.3) |
| History of admission within the past 1 yr | 18 (52.9) |
| History of anaerobic antibiotic use within the past 3 months | 5 (14.7) |
| History of anaerobic antibiotic use within the past 1 yr | 10 (29.4) |
| Hypotension | 8/33 (24.2) |
| Inotropics | 4/33 (12.1) |
| Type of infection | |
| Intra-abdominal | 20 (58.8) |
| Skin and soft tissue | 5 (14.7) |
| Empyema | 3 (8.8) |
| Others | 6 |
| Clinical severity | |
| Charlson comorbidity index | 2.6±2.8 |
| Pitt’s bacteremia score | 0.9±1.4 |
| Therapeutic interventions | |
| Use of anaerobic coverage antimicrobials within 48 hrs after culture | 28 (82.4) |
| Surgical intervention | 7 (20.6) |
| Outcomes | |
| 30-day mortality, all-cause | 5 (14.7) |
| 30-day mortality, infection-related | 2 (5.9) |
| Laboratory findings | |
| White blood cells (×109/L) | 16.4±7.1 |
| C-reactive protein (mg/L) | 221±114 |
| Blood urea nitrogen (mmol/L) | 14.75±14.78 |
| Creatinine (µmol/L) | 194.52±254.42 |
Continuous variables are presented as mean±standard deviation.
Categorical variables are presented as N (%).
*These included complicated urinary tract infection (N=2), pyogenic arthritis (N=1), osteomyelitis (N=1), acute cholangitis (N=1), and primary bacteremia (N=1).
Ann Lab Med 2025;45:223~227 https://doi.org/10.3343/alm.2024.0369
© Ann Lab Med